Date published: 2025-10-7

1-800-457-3801

SCBT Portrait Logo
Seach Input

CNP Inhibitors

CNP inhibitors constitute a chemically diverse class of compounds known for their intricate involvement in cellular modulation. These inhibitors exert their effects by selectively targeting cyclic nucleotide phosphodiesterase enzymes, which are responsible for the breakdown of cyclic guanosine monophosphate (cGMP) and cyclic adenosine monophosphate (cAMP) molecules. These cyclic nucleotides serve as crucial secondary messengers, transducing extracellular signals into intracellular responses. By inhibiting phosphodiesterases, CNP inhibitors disrupt the normal degradation of cGMP and cAMP, leading to an accumulation of these molecules within the cell. The class of CNP inhibitors encompasses a wide array of chemical structures, allowing for a range of binding interactions with different phosphodiesterase isoforms. This structural diversity contributes to the selectivity of CNP inhibitors, enabling researchers to finely tune their inhibitory effects on specific phosphodiesterase enzymes. This selectivity, in turn, results in the modulation of distinct intracellular pathways and processes, such as vasodilation, neurotransmitter release, cellular proliferation, and immune responses. CNP inhibitors have attracted significant attention from the scientific community due to their potential impact on cellular communication and homeostasis. By perturbing cyclic nucleotide levels, these inhibitors offer a window into the intricate network of signaling cascades that govern various physiological responses. Researchers utilize CNP inhibitors as powerful tools to dissect the complexity of these signaling pathways and uncover the underlying mechanisms of cellular function. CNP inhibitors constitute a versatile chemical class with the unique ability to manipulate cellular processes by inhibiting cyclic nucleotide phosphodiesterase enzymes. Their modulation of cyclic nucleotide levels influences diverse cellular functions, and their selectivity for different phosphodiesterase isoforms provides a nuanced approach to dissecting intracellular signaling pathways. The exploration of CNP inhibitors sheds light on the intricacies of cellular communication and holds promise for unveiling novel insights into physiological regulation.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Vardenafil

224785-90-4sc-362054
sc-362054A
sc-362054B
100 mg
1 g
50 g
$516.00
$720.00
$16326.00
7
(1)

Similar to sildenafil, vardenafil influences cAMP and cGMP levels, resulting in smooth muscle relaxation and vasodilation.

Tadalafil

171596-29-5sc-208412
50 mg
$176.00
13
(2)

Like sildenafil and vardenafil, tadalafil modulates cAMP and cGMP levels, impacting vascular tone.

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$75.00
$212.00
18
(1)

Selectively inhibits phosphodiesterase type 4 (PDE4), indirectly raising cGMP levels and affecting cell signaling.

Dipyridamole

58-32-2sc-200717
sc-200717A
1 g
5 g
$30.00
$100.00
1
(1)

Besides its primary effects, dipyridamole inhibits various phosphodiesterases, impacting cGMP levels and vascular function.

Zardaverine

101975-10-4sc-201208
sc-201208A
5 mg
25 mg
$88.00
$379.00
1
(0)

A non-selective phosphodiesterase inhibitor, affecting cAMP and cGMP levels, potentially influencing cellular processes.

Milrinone

78415-72-2sc-201193
sc-201193A
10 mg
50 mg
$162.00
$683.00
7
(0)

Selective phosphodiesterase 3 (PDE3) inhibitor, increasing cAMP levels.

Ibudilast

50847-11-5sc-203080
10 mg
$214.00
1
(1)

Mainly a PDE4 inhibitor, ibudilast also affects cyclic nucleotide levels, influencing immune modulation.